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Background & aims: Cancer is one of the leading causes of death for children; however, appropriate
nutritional status can positively affect disease progression and outcome. The aim of this study was to
present our self-developed nutritional risk screening method, relate it to another validated tool and to
objective bio-impedance measures. We intended to recommend a screening algorithm which can be
used in our pediatric oncology facilities.
Methods: We analysed data from 109 pediatric oncology patients (age 3e18) at the 2nd Department of
Pediatrics, Semmelweis University between 2017 and 2018. The nutritional status was assessed by the
Nutrition screening tool for childhood cancer (SCAN), Nutrition risk screening for pediatric cancer (NRS-
PC) our own self-developed screening tool and Bio-impedance analysis (InBody 720 and S10). Classifier
properties for low muscle mass measured by Bio-impedance analysis were compared for SCAN and NRS-
PC in the overall sample and in the different phases of the disease.
Results: The AUC of 0.67 [95% CI:0.58,0.75] of the SCAN was significantly lower (Z ¼ 2.46, p ¼ 0.014)
than in the case of the NRS-PC (AUC ¼ 0.75 [95% CI:0.67,0.82]), indicating that NRS-PC has better clas-
sifier properties to identify children with lower muscle mass. No significant difference was found in the
different phases of the disease.
Conclusions: Based on our results, we suggest screening high BMI patients first with NRS-PC. However, in
case of low BMI bio-impedance measures provide more precise information on muscle mass and
nutritional risk. Further data are needed to decide whether the NRS-PC is sensitive enough in normal BMI
patients.
© 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Cancer is one of the leading causes of death for children, with
approximately 300,000 new cases diagnosed each year among
children aged 0e19 years [1,2]. The aim of WHO's Global Initiative
for Childhood Cancer, which was announced in 2018 September, is
to reach at least 60% survival rate by 2030 [3]. In order to achieve
better clinical outcome appropriate nutritional screening and
therapy are required as it has been suggested in a number ofr childhood cancer; NRS-PC,
io-impedance analysis; AUC,
istics; BMI, Body mass index;
aorsi street, Hungary.
r Ltd. This is an open access articleprevious studies. Similarly to adult cancer patients these studies
have revealed that optimising nutritional status of the patients
have a positive effect on event free survival, treatment toxicity and
quality of life as well [1,2,4]. Since there are no specific clinical
nutrition guidelines on how to assess the nutritional state and how
to provide adequate nutrition support for pediatric cancer patients,
it can be challenging for professionals.
It has been long ascertained that the nutritional status in case of
chronic wasting diseases, especially in case of childhood cancer,
does influence the outcome of the disease, the course of the ther-
apy, including treatment tolerance and infection risk, not to
mention the quality of life and the cost of care [5,6]. It is also known
that the tumour itself means a risk for malnutrition, especially in
case of children. The most common categories of childhood cancers
include leukaemia, brain tumors, lymphomas and solid tumours
[7]. Several types of childhood cancers are associated with highunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tumors - prevalence 26%, Wilm's tumor Stage III and IV. e preva-
lence 5% Ewing-, and Osteosarcoma - prevalence 4%) since due to
aggressive treatment protocols (surgery, stem cell transplant,
chemo-, radiation therapy), which patients have to endure, nutri-
tional status declines and thus the risk for malnutrition increases
significantly.
It is already known that pediatric oncology patients tend to have
lower fat free mass (FFM) at diagnosis and remains low during the
treatment [8,9]. The decrease in fat free mass is often accompanied
by increased fat mass, which strongly correlates with low or
reduced physical activity [8,9]. Relying on BMI alone is misleading
since it does not show the underlying body composition changes;
therefore assessing the body composition is essential.
In the ESPEN Guideline on nutrition in cancer patients it is
highlighted that weight loss and decrease in BMI negatively influ-
ence survival. The grading scheme (grades 0e4) predicts overall
survival, where 0 means best, 4 means worst prognosis [10].
Another study suggested that 71.7% of the body mass loss was lean
body mass (LBM) [11].
Although a number of screening tools have been developed,
mainly for general pediatric patients, none of themmet the specific
requirements of pediatric cancer patients. Later in 2016 SCAN was
published [12], the validity of which was tested against pediatric
subjective global nutritional assessment (SGNA). In the present
study we aimed to validate both SCAN and our self-developed
screening tool (NRS-PC) to bio-impedance measures. As it was
mentioned above, bio-impedance measures can assess the body
composition (including fat free mass and fat mass) and it is of key
importance when we decide on the nutrition therapy of children
with cancer. The aim of our research was also to create a screening
algorithm which would help professionals decide which screening
method to use and when to use them.
2. Material and methods
In this study we analysed data from 109 pediatric oncology
patients (age 3e18) at the 2nd Department of Pediatrics, Semmel-
weis University (Budapest, Hungary) who were inpatients between
2017 and 2018. Data were collected during the different phases of
the disease: Diagnosis (the time between histological sampling and
the initiation of cancer treatment e usually a couple of days or
maximum few weeks), Active treatment (intensive chemotherapy
until the last day of intravenous chemotherapy), Maintenance (oral
low-dose chemotherapy mostly in leukemias and some soft tissue
sarcomas) and Post therapy (during the follow-up period, after
completing all therapies) with the approval of the Hungarian Sci-
entific and Research Ethics Committee (number: 86,748/AOGY2/
2016). During the study period, in total 156 bio-impedance mea-
sures were done, however some patients were measured more
than once, but only if they proceeded to the next phase of the
disease. 14 of the patients had a disease relapse, which means the
reappearance of their malignancy.
Bio-impedance measures were performed by a clinical dietician
who is alsomember of the nutrition support team. Patients were on
an empty stomach; those who were physically fit enough to stand
alone for 1.5 min were measured by InBody 720, and those who
were not, were measured by InBody S10 in a seated position
(InBody Co. Ltd. 13,850 Cerritos Corporate Drive, Unit C, Cerritos, CA
90703).
Recorded parameters were the following: name, age (date of
birth), diagnosis, date of the measurement, phase of the disease,
weight, height (using standardized scales and stadiometers);
calculated parameters were: SCAN score and NRS-PC score. BMI3837and body composition parameters including muscle mass and body
fat percentagewere determined by the InBody devices. BMI, muscle
mass and body fat percentagewere compared against normal range
values. Three categories were set up regarding BMI, muscle mass
and body fat mass: low, normal, and high which were also deter-
mined and provided by the InBody devices.
Three different screening tools were used to assess the nutri-
tional status of the patients:
SCAN: nutrition screening tool for childhood cancer is a simple
and quick tool to identify children with cancer who are at risk of
malnutrition. It was validated and published in 2016. SCAN includes
six Yes or No questions and if the total score is 3 it means being at
risk of malnutrition. The patient has to be referred to a dietician for
further assessment (For further details see Appendix 1).
NRS-PC: nutrition risk screening for pediatric cancer, which is
our self-developed screening tool. Similarly to SCAN it is also an
easy-to-use questionnaire with a score system. Apart from six
questions regarding weight loss, physical activity, change in
nutrition habits, stool and other gastrointestinal symptoms the BMI
percentiles are also taken into consideration (For further details see
Appendix 2). Scores are given according to the number of positive
answers (Questions 1e6).
BIA Bioelectrical Impedance Analysis is used to measure body
composition. InBody 720 and S10 are medical-grade body compo-
sition analyzers, which rely on four technological milestones (8-
point tactile electrode system, direct segmental measurements,
multiple frequencies, no estimations) to provide accurate and
precise results that are highly correlated to gold-standard methods
[13]. Our final results included three categories (low, normal or
high) regarding BMI, muscle mass and body fat percentage (one by
one) that has been shown to determine body composition inde-
pendently of age, ethnicity or gender.
One of our primary goals was to evaluate NRS-PC tomusclemass
measured by bio-impedance analysis. Based on thesemeasures two
categories were created: low muscle mass and normal or high
muscle mass. The individual muscle mass values were defined by
the body composition analysis, provided by InBody 720 or S10
devices. A receiver-operator characteristic curve was used to assess
the relationship between muscle mass category and the different
cut-off scores of the NRS-PC. The area under the curve (AUC) was
calculated to measure classifier performance.2.1. Statistical analysis
Descriptive statistics were used for the presentation of de-
mographic data. A receiver-operator characteristic curve was used
to assess the relationship between SCAN, NRS-PC and bio-
impedance measures. To compare children who were at low and
at high risk for malnutrition according to NRS-PC we used Chi-
square test (categorical variables) and t-test (continuous vari-
ables). Significance was set at p < 0.05. All statistical analysis was
done in R (version 3.6.1), for receiver-operator characteristic curve
analysis, ROCR and epiR packages were used.3. Results
The data of 109 patients were analyzed (n ¼ 64 males). Some of
the children underwent repeated assessments at different phases
of their disease (see Table 1). 77 patients went through one
assessment, 21 two and 11 patients three assessments. Children
had a mean age of 11.3 years (range: 3e21 years, SD ¼ 4.8 years).
The incidence of the different tumor types can be seen is Table 2. 14
of the patients had a disease relapse.
Table 1
The characteristics of the study subjects.
Phase of the disease Number of cases (n ¼ ) Male: Female ratio Age (years) Lost patients (n ¼ ) Relapse (n ¼ ) SCAN score NRS-PC score
Diagnosis 44 29:15 10.5 ± 3.5 1 9 3.4 ± 2.0 1.0 ± 1.3
Active treatment 36 22:14 14.5 ± 3.5 4 1 3.4 ± 1.6 1.2 ± 1.3
Maintenance 34 19:15 9.5 ± 4.5 0 0 2.9 ± 1.7 0.5 ± 1.0
Post therapy 36 22:14 11.5 ± 2.5 1 4 1.7 ± 1.4 0.4 ± 0.9
Data are expressed as mean ± SD.
Table 2
The incidence of different tumor types.
Tumor types Number of
patients (n ¼ )
ALL 39
AML 6
Ewing sarcoma and Osteosarcoma 23
Brain and spinal tumors (Medulloblastoma,
Neuroblastoma, PNET e Central nervous system)
21
Other (Wilms-tumor, Hepatoblastoma,
Melanoma, Colon cancer etc.)
20
Fig. 1. ROC curve demonstrating the predictive value of NRS-PC to SCAN with a cut off
score of 3.
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As a first step, NRS-PC was compared to SCAN, a validated
nutrition assessment tool used in pediatric oncology, to identify cut
off scores for NRS-PC. According toMurphy et al. (2016), a child was
classified at risk of malnutrition if the SCAN score was equal or
greater than three. A receiver-operator characteristic curve was
used to assess the relationship between SCAN and the different cut-
off scores of the NRS-PC. The area under the curve (AUC) showed a
high classifier performance (AUC ¼ 0.9) (Fig. 1). A cut off score of
one on the NRS-PC resulted in 98% [95% CI: 90, 100] sensitivity, 62%
[95% CI: 51, 71] specificity, a positive predictive value of 58% [95% CI:
47, 68] and a negative predictive value of 98% [95% CI: 91, 100]. This
means that in our sample one child considered malnourished by
the SCAN would have been undetected with our questionnaire. A
cut off score of two would decrease the sensitivity to 86% [95% CI:
77, 93], while increasing the specificity to 77% [95% CI: 65, 86]. As
we aimed to identify all children at risk of malnutrition sensitivity
was prioritised over specificity.
4. Evaluation of NRS-PC to bio-impedance measures
In order to evaluate NRS-PC to muscle mass measured by bio-
impedance analysis low muscle mass and normal or high muscle
mass categories were set up. A ROC curve was used to assess the
relationship between the muscle mass category and the different
cut-off scores of the NRS-PC. The area under the curve (AUC) was
calculated to measure classifier performance. Sensitivity, speci-
ficity, negative and positive predictive values were calculated to
each cut-off score and were reported in Table 3. Ideally, a mea-
surement tool should have a 100% sensitivity to identify every child
who has low muscle mass. A cut off score of one would give a
sensitivity of 75% with 60% specificity. In our sample, this means
that 13 childrenwould have been incorrectly classified to the group
of normal muscle mass, while 40 children would be incorrectly
classified to the low muscle mass group.
4.1. Comparison of NRS-PC and SCAN predictive value regarding
muscle mass
To evaluate whether the SCAN or the NRS-PC questionnaire was
a more sensitive tool to identify patients with reduced muscle3838mass, we did ROC analysis and compared the AUC values of both
questionnaires with the DeLong method. The AUC of 0.67 [95% CI:
0.58, 0.75] of the SCAN was significantly lower (Z ¼ 2.46, p-
value ¼ 0.014) than in the case of the NRS-PC (AUC ¼ 0.75 [95% CI:
0.67, 0.82]), indicating that NRS-PC has better classifier properties
to identify children with lower muscle mass (Fig. 2).
4.2. Evaluating the NRS-PC and SCAN at different phases of the
disease
Patients were assessed at different phases of the course of their
treatment. The description of the four phases and the number of
participant in each case are shown in Table 4. To assess whether the
classifier performance of NRS-PC differs at the different phases of
the treatment, ROC analysis was performed. The AUC values at the
different phases did not differ significantly from each other.
4.3. Evaluating BMI categories
Classifier performance of both questionnaires was evaluated in
the three BMI categories separately. There were no significant dif-
ferences in the AUC values of the two screening tools, however, in
the low and normal BMI groups the result of the DeLong test
approached significance. In the low BMI group, SCAN had better
classifier properties, whereas in the normal BMI group, NRS-PC
seemed to be better. Nevertheless, neither of the tests had suffi-
cient sensitivity in the low BMI group (see Tables 5 and 6).
4.4. Comparing children under and over NRS-PC cut-off
Comparing children at low risk for malnutrition to those at high
risk according to NRS-PC no significant differences were found in
gender, the proportion of patients after relapse or age. However,
therewas a significant difference in the phase of the disease and the
Table 3
Validation of NRS-PC to muscle mass. 95% confidence intervals are in [].
Cut off score Sensitivity Specificity Negative predictive value Positive predictive value
1 0.75 [0.62, 0.86] 0.6 [0.49, 0.69] 0.82 [0.71, 0.9] 0.5 [0.39, 0.61]
2 0.7 [0.59, 0.79] 0.71 [0.58, 0.81] 0.64 [0.52, 0.75] 0.76 [0.65, 0.85]
3 0.62 [0.53, 0.71] 0.82 [0.65, 0.93] 0.38 [0.26, 0.5] 0.92 [0.84, 0.97]
4 0.59 [0.5, 0.68] 0.9 [0.68, 0.99] 0.25 [0.16, 0.37] 0.97 [0.91, 1]
5 0.54 [0.45, 0.62] 1 [0.29, 1] 0.04 [0.01, 0.12] 1 [0.95, 1]
Fig. 2. ROC curve demonstrating the predictive value of the SCAN and the NRS-PC for
low muscle mass. The AUC of NRS-PC (0.75) was significantly larger than the AUC
(0.67) of SCAN.
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phases 1e3, whereas less in phase 4. It is also clear that children in
the low BMI category were almost all at high risk (except for 3
patients) for having low muscle mass.5. Discussion
In the current study on pediatric cancer patients we provide a
comparative analysis of the already validated SCAN, our self-
developed NRS-PC score system and bio-impedance measures,
the latter of which present objectively measured body composition
parameters owing to a modern clinically used device.
It is known that among pediatric oncology patients the preva-
lence of malnutrition is high [14,15]. Therefore, screening for
malnutrition risk to identify and triage patients who need further
assessment and nutritional intervention may contribute to the so-
lution of this problem. It is vital to have a nutritional screening tool
which is quick, easy to use and can be performed by the nursing
staff, since in busy pediatric hospitals and oncology units dieticians
have limited capacity and in some centers NSTs might not be
available.
There are certain validated nutrition screening tools for pedi-
atric patients e.g. STRONGkids, Pediatric Yorkhill Malnutrition
Score (PYMS), Screening Tool for Assessment of Malnutrition in
Pediatrics (STAMP), Pediatric Nutrition Screening Tool (PNST),
Subjective Global Nutritional Assessment (SGNA) however, theseTable 4
Comparison of SCAN and NRS-PC at different phases of the disease.
Description Number of cases NRS-PC A
Assessment after diagnosis 44 0.67 [0.49
Active treatment 36 0.78 [0.63
Maintenance 35 0.77 [0.62
Assessment post therapy 37 0.82 [0.67
3839have been designed for general patients [16e20]. STRONGkids,
which is highly recommended in the EU - since it is fast, and easy to
use - can also be used in case of general pediatric diseases. Ac-
cording to STRONGkids all cancers belong to the „medium risk”
category, thus it does not distinguish malnourished cancer patients
[16].
Prior to 2012 only weight loss was considered as an indicator of
malnutrition risk, but there was no nutrition assessment at our
hospital. In 2012 with the foundation of the nutrition support team
(NST) we started to develop our own disease specific malnutrition
risk screening tool in order to find a quick and simple process to
identify children who are malnourished or at risk of malnutrition.
This is essential in case of pediatric cancer patients to be able to
decide who is in need of further assessment, dietetic counsel, oral
nutritional supplementation or any other nutritional intervention.
In this study we aimed to assess whether NRS-PC is suitable for
these purposes and could be used at any phase of the disease. Since
SCAN was already available during our study period it was possible
to use both SCAN and NRS-PC on our sample. Previously, SCAN was
evaluated against pediatric SGNA, in that study 32 subjects were
involved, whereas in our study the data of 109 patients were ana-
lysed [12]. In Murphy's SCAN article air displacement plethys-
mography - Body Pod Body Composition System - was used to
measure body volume, fat mass and fat free mass, whereas we used
bio-impedance measures and InBody body composition devices. In
a 2019 study these methods were compared to dual energy x-ray
absorptiometry (DXA) and was concluded that both Body Pod and
InBody 770 overestimate fat free mass and underestimate fat mass
and percent body fat [21]. This however, does not influence our
results. Relying on this information and the cited article, both
methods are acceptable for body composition analysis.
5.1. Developing a screening algorithm for the nutritional status of
pediatric oncology patients
First and foremost, wewanted to compare SCAN and our NRS-PC
questionnaire in order to decide which was more sensitive to
identify patients with reduced muscle mass. Although body
composition studies in pediatric cancer are limited and existing
literature in this area has largely focused on hematologic malig-
nancies, it is known that the loss of muscle mass adversely affect
clinical outcome and survival both in adult and pediatric cancer
patients [22,23]. Our results indicated that NRS-PC has better
classifier properties to identify children with lower muscle mass.
However, evaluating the NRS-PC and SCAN at the different phases
of the disease we found that they did not differ from each otherUC SCAN-AUC Z p
0.86] 0.62 [0.45 0.8] 0.88 0.381
0.93] 0.7 [0.53 0.86] 1.29 0.196
0.93] 0.64 [0.46 0.81] 1.8 0.072
0.96] 0.67 [0.49 0.84] 1.57 0.115
Table 5
Comparison of SCAN and NRS-PC at different BMI categories.
Number of cases NRS-PC AUC SCAN-AUC Z p
Low 27 0.5 [0.22 0.78] 0.62 [0.31 0.93] 1.86 0.063
Normal 99 0.72 [0.61 0.81] 0.64 [0.54 0.75] 1.75 0.081
High 25 0.83 [0.54 1] 0.74 [0.22 1] 0.77 0.439
Table 6
Comparison of low and high nutritional risk patients (based on bio-impedance measurements). For categorical variables, chi square tests, for age independent samples t-test
were used for comparison.
Low risk High risk p
Gender Male 37 56 0.150
Female 16 43
Relapse No 47 91 0.720
Yes 6 8




BMI category Low 3 24 0.001
Normal 35 64
High 15 10
Age 10.7 11.6 0.270
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high) therewere no significant differences between them, although
in the low and normal BMI groups the DeLong test approached
significance.
As children in the low BMI category were almost all at high risk
and as the ROC curve of NRS-PC does not show appropriate validity
to identify those who have low muscle mass, we suggest bio-
impedance measures in every patient with low BMI. In our sam-
ple, there were only two children who had normal muscle mass in
spite of their low BMI.
In case of normal BMI, we need further studies to assess
whether the NRS-PC is sensitive enough to identify approximately
all patients with low muscle mass. In our sample, a first screening
with NRS-PC would result in overlooking 13 children with low
muscle mass. However, out of the 13 children, 3 did have normal
muscle mass at the subsequent assessment, 1 had similarly low
muscle mass and we did not have data from the other 9. Existing
literature reinforces that during the course of cancer therapy body
composition can change considerably [8,9,24,25]. Therefore, lon-
gitudinal data would be advantageous to decide whether it is safe
to rely on NRS-PC without bio-impedance measures.
In the high BMI group, we suggest screening with NRS-PC first.
None of the patients with low muscle mass would have been un-
detected in our sample with this strategy, and out of the three
children who were identified being at high risk, at the subsequent
assessments two had low muscle mass.6. Conclusions
As a conclusion we can affirm that assessing the nutritional
status of pediatric cancer patients by anymeans is proved to be very
useful and can contribute to the necessary dietetic interventions.
Derived from our results we suggest screening high BMI patients
first with NRS-PC. In case of low BMI bio-impedance measures
provide more precise information on muscle mass and nutritional
risk. Further data are needed to decide whether the NRS-PC is
sensitive enough in case of normal BMI patients. Using specific
screening tools and following a screening algorithm facilitates the
assessment and supplies more accurate information based on3840which better nutritional care can be administered. The assessment
of nutritional status and the implementation of nutrition therapy
accordingly may contribute to better outcome and survival in pe-
diatric cancer patients.
6.1. Limitations
In this single center study during the research period we had a
limited number of patients who could be involved. In the current
study we could not collect longitudinal data however, it would be
beneficial to follow patients from the diagnosis until the comple-
tion of their treatment in order to further evaluate the use and
accuracy of the NRS-PC.
Funding
No specific grant or funding was used for this study.
Author contribution statement
I declare that all authors approved the manuscript submitted.
Individual contribution is stated below:
Conception and design: NG, KH, ET, GK.
Data collection: NG, KC, EF.
Analysis and interpretation: NG, KC, ET, KH, GK.
Drafting of the manuscript: NG, KH, GK.
Revising the manuscript for content: NG, KC, ET, KH, EF, GK.
Conflict of interest
The authors declare that no conflict of interest exist in this study.
Acknowledgements
The authors would like to thank the members of the nutrition
support team and all the employees of the 2nd Department of
Pediatrics, Semmelweis University for their active participation in
this study.
N. Gallo, K. Horvath, K. Czuppon et al. Clinical Nutrition 40 (2021) 3836e3841Appendix AAppendix 1
Nutrition screening tool for childhood cancer (SCAN).
Does the patient have a high risk cancer? 1
Is the patient currently undergoing intensive treatment? 1
Does the patient have any symptoms relating to the GI tract? 2
Has the patient had poor intake over the past week? 2
Has the patient had any weight loss over the past month? 2
Does the patient show signs of under nutrition? 2
Total:
Score indication.
3 At risk of malnutrition e Refer to dietician for further assessment.Appendix 2
NRS-PC (Nutrition Risk Screening for Pedatric Cancer) Questionnaire
- New or returning patient:
- Name:






- Does the patient receive any nutritional supplement? Yes or No
- Does the patient have a feeding tube upon admission? Yes or No
- BMI percentile <10? Yes or No
- BMI percentile <5? Yes or NoQuestions YES NO
1. More than 1 kg weight loss since tumor associated complaints
and symptoms
2. Change in nutrition habits: reduced amount of food consumed
3. Change in nutrition habits: fewer occasions (compared to
previous number of meals)
4. Stool is more frequent than usual or change in consistency
5. Increased vomiting compared to earlier
6. Reduced physical activity compared to earlier (before diagnosis)
NRS-PC score (number of positive responses from
Questions 1e6)
Date.
Screening done by (name of the person).References
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